Fig. 2From: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trialStandard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure with overview of the study proceduresBack to article page